---
title: 7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined
  and Standalone Usage
date: '2024-02-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38363465/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240216170700&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: iStent inject implantation with or without phacoemulsification
  produced significant and durable 7-year reductions in IOP (~ 34-44% reduction) and
  medications (~ 58-76% reduction) while preventing filtering surgery in this cohort
  of patients with relatively high preoperative disease burden. Combined and Standalone
  cases had similarly favorable effectiveness and ...'
disable_comments: true
---
CONCLUSION: iStent inject implantation with or without phacoemulsification produced significant and durable 7-year reductions in IOP (~ 34-44% reduction) and medications (~ 58-76% reduction) while preventing filtering surgery in this cohort of patients with relatively high preoperative disease burden. Combined and Standalone cases had similarly favorable effectiveness and ...